Hanene Ali-Boucetta, MPharm, PhD
Affiliations: | 2001-2012 | School of Pharmacy | University of London, London, England, United Kingdom |
2012- | School of Pharmacy | University of Birmingham, Birmingham, England, United Kingdom |
Website:
https://www.birmingham.ac.uk/staff/profiles/clinical-sciences/Ali-Boucetta-Hanene.aspxGoogle:
"Hanene Ali-Boucetta"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Niezabitowska E, Smith J, Prestly MR, et al. (2018) Facile production of nanocomposites of carbon nanotubes and polycaprolactone with high aspect ratios with potential applications in drug delivery. Rsc Advances. 8: 16444-16454 |
Ménard-Moyon C, Ali-Boucetta H, Fabbro C, et al. (2015) Controlled Chemical Derivatisation of Carbon Nanotubes with Imaging, Targeting, and Therapeutic Capabilities. Chemistry (Weinheim An Der Bergstrasse, Germany). 21: 14886-92 |
Ali-Boucetta H, Kostarelos K. (2013) Carbon nanotubes in medicine & biology - therapy and diagnostics. Advanced Drug Delivery Reviews. 65: 1897-8 |
Ali-Boucetta H, Kostarelos K. (2013) Pharmacology of carbon nanotubes: toxicokinetics, excretion and tissue accumulation. Advanced Drug Delivery Reviews. 65: 2111-9 |
Lacerda L, Ali-Boucetta H, Kraszewski S, et al. (2013) How do functionalized carbon nanotubes land on, bind to and pierce through model and plasma membranes. Nanoscale. 5: 10242-50 |
Bitounis D, Ali-Boucetta H, Hong BH, et al. (2013) Prospects and challenges of graphene in biomedical applications. Advanced Materials (Deerfield Beach, Fla.). 25: 2258-68 |
Ali-Boucetta H, Nunes A, Sainz R, et al. (2013) Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. Angewandte Chemie (International Ed. in English). 52: 2274-8 |
Ali-Boucetta H, Bitounis D, Raveendran-Nair R, et al. (2013) Purified graphene oxide dispersions lack in vitro cytotoxicity and in vivo pathogenicity. Advanced Healthcare Materials. 2: 433-41 |
Bussy C, Ali-Boucetta H, Kostarelos K. (2013) Safety considerations for graphene: lessons learnt from carbon nanotubes. Accounts of Chemical Research. 46: 692-701 |
Ali-Boucetta H, Nunes A, Sainz R, et al. (2013) Inside Cover: Asbestos-like Pathogenicity of Long Carbon Nanotubes Alleviated by Chemical Functionalization (Angew. Chem. Int. Ed. 8/2013) Angewandte Chemie International Edition. 52: 2130-2130 |